Elizabeth Lieu to Lung Neoplasms
This is a "connection" page, showing publications Elizabeth Lieu has written about Lung Neoplasms.
Connection Strength
0.185
-
Concurrent loss of LKB1 and KEAP1 enhances SHMT-mediated antioxidant defence in KRAS-mutant lung cancer. Nat Metab. 2024 Jul; 6(7):1310-1328.
Score: 0.104
-
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer. Nat Metab. 2020 12; 2(12):1401-1412.
Score: 0.081